ResMed Inc.(RMD)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Instruments & Supplies
ResMed Inc. logo

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest News & Analysis

ResMed NightOwl: At-home sleep apnea test. Is RMD stock a buy? Reviewing financial health, AI, and the CPAP market for investors.
Apr 9, 2025

ResMed's NightOwl: Transforming Sleep Apnea Diagnostics and RMD Stock

ResMed (RMD) is innovating sleep apnea diagnostics with NightOwl, an at-home test. Financial analysis reveals strong fundamentals. Upcoming Q3 2025 earnings are eagerly anticipated.

Read more →
ResMed's AI-powered CPAP therapy: Revolutionizing sleep apnea treatment and enhancing patient lives. Learn about the latest advancements.
Mar 24, 2025

ResMed (RMD): AI, Brand Unification, and CPAP Therapy

ResMed is revolutionizing sleep apnea treatment with AI and brand unification. A Lancet study confirms CPAP therapy's life-saving benefits, boosting ResMed's market position.

Read more →
ResMed CPAP machine for sleep apnea therapy: Financial analysis of market trends and technological advancements.
Mar 20, 2025

ResMed (RMD): CPAP Study, Brand Unification, and AI Innovation – A Financial News Analysis

ResMed (RMD) advances with CPAP study validation, brand unification, and AI innovation. Financial analysis of recent developments and strategic moves.

Read more →
ResMed: CPAP Therapy, AI Innovation, and Financial Outlook | Investment Analysis
Mar 19, 2025

ResMed (RMD): CPAP Therapy, AI Innovation, and Financial Outlook

ResMed (RMD) advances in sleep therapy, AI, and brand unification. Strong financials and a reliable dividend make RMD a compelling investment in the growing sleep apnea market.

Read more →
ResMed's strategic brand unification and AI investments drive growth in the sleep and respiratory care market. Learn how these initiatives and RMD's financial stability impact its stock performance and future potential.
Mar 14, 2025

ResMed (RMD): Brand Strategy, AI Investment, and Market Impact

Analysis of ResMed's brand unification, AI investments, and financial strategy. Examines market impact, debt management, and growth opportunities in sleep apnea.

Read more →
ResMed's brand strategy, AirSense platform, and financial health analysis. Learn about ResMed's market share, dividend strategy, and the impact of the Philips recall.
Mar 11, 2025

ResMed's Unified Brand: Revolutionizing Sleep and Health Technology

ResMed's brand evolution unifies its portfolio, enhancing direct-to-consumer engagement. Strong financials, driven by AirSense and Philips recall, position RMD for growth.

Read more →
ResMed financial analysis: market performance, revenue growth, and innovative strategies.
Mar 6, 2025

ResMed Inc. Financial Update: Earnings, Growth & Strategic Developments

Deep-dive analysis of ResMed Inc. fundamentals, market performance, and strategic initiatives driving its future growth.

Read more →
ResMed (RMD) stock analysis: growth, market impact, sleep apnea trends.
Feb 28, 2025

ResMed (RMD): Analyzing Growth, Market Impact, and Industry Trends

Analyzing ResMed's growth, market impact, and industry trends in sleep and respiratory care. An in-depth look at RMD's strategy and competitive landscape.

Read more →
ResMed stock analysis: growth drivers, sleep apnea market trends, and digital health future. Explore RMD's Q2 FY25 results, GLP-1 impact, and 2030 strategy.
Feb 27, 2025

ResMed (RMD): Analyzing Growth Drivers, Market Trends, and Future Outlook

ResMed (RMD) demonstrates strong growth potential driven by robust Q2 FY25 results, increasing sleep apnea awareness, and strategic digital health initiatives.

Read more →
ResMed strategy and market analysis: Trends, competition, and future growth in sleep apnea and respiratory care solutions.
Feb 26, 2025

ResMed: Strategy, Market Impact, and Industry Trends in 2025

ResMed's 2030 strategy, digital health initiatives, and market trends analyzed. Wearable tech, cloud solutions, and healthcare policy impacts assessed.

Read more →
ResMed financial analysis: Performance, market strategy, and future outlook for sleep apnea treatment and wearable tech integration.
Feb 25, 2025

ResMed: Financial Performance, Market Strategy, and the Future of Sleep Apnea Treatment

ResMed's Q2 FY25 results show strong growth driven by AirSense 11 and efficient cost management. Wearable tech integration and strategic initiatives enhance long-term potential.

Read more →
ResMed's strategy for growth amidst market shifts and GLP-1 competition in 2025. ResMed stock analysis and future outlook.
Feb 24, 2025

ResMed Navigates Market Shifts and Competitive Pressures in 2025

ResMed navigates a dynamic market with strong Q2 FY25 results, driven by AirSense 11 and cost management. Digital health is key, but GLP-1s pose a challenge.

Read more →
ResMed: Leading sleep apnea solutions, driven by innovation and strong financial performance. Explore growth potential and market trends.
Feb 21, 2025

ResMed’s Growth Trajectory: Navigating Market Trends and Innovation in Sleep Apnea Solutions

Explore ResMed’s Q2 2025 performance, innovative product portfolio, and strategic market trends driving growth in the sleep apnea solutions industry.

Read more →
Person sleeping peacefully, representing sleep and health.
Feb 18, 2025

ResMed’s Strategic Growth: Market Expansion and Sleep Apnea Solutions

A comprehensive analysis of ResMed’s Q2 2025 performance, market trends, and strategic initiatives that drive growth.

Read more →
ResMed Inc. (RMD) News & Analysis | Monexa | Monexa